- SEK12.88bn
- SEK12.36bn
- SEK1.54bn
Brief: Biogaia AB Says Annwall & Rothschild Investments To Sell Biogaia Shares To Anatom
Brief: Biogaia Targets Operating Margin Of At Least 34%
Brief: BioGaia Q4 Net Income SEK 81.9 Million
Brief: BioGaia Q4 EBIT SEK 103 Million
Brief: BioGaia Q3 Net Income SEK 36.6 Million
Brief: Biogaia AB Operating Profit For Q3 Is Preliminarily Estimated At SEK 41 Million
Brief: BioGaia Q3 EBIT SEK 41 Million
Brief: Carnegie Says EQT Public Value To Sell About 6 Mln B-Shares, 5% Of Votes Outstanding In Biogaia AB
Brief: Biogaia Q2 Operating Profit Up At SEK 135.4 Mln
Brief: Biogaia Sales In Emea Increased By 13%
Brief: BioGaia Q1 Net Income SEK 121.8 Million
Brief: Biogaia Proposes Ordinary Dividend Of SEK 1.90 Per Share
Brief: BioGaia Q4 Net Income SEK 67.4 Million
Brief: BioGaia Q3 Net Income SEK 101.5 Million
Brief: BioGaia Q3 EBIT SEK 120 Million
Brief: Biogaia, University Of Gothenburg Reach Important Milestone Towards Next-Generation Probiotics
Brief: BioGaia Appoints Theresa Agnew As New CEO
Brief: BioGaia Q2 Net Income SEK 80.5 Million
Brief: Biogaia's Probiotic Protectis Increases Sars-Cov-2 Antibody Response